Petrus Bekker, SVP of Medical & Clinical at ChemoCentryx, Inc. (CCXI), sold 5,000 shares at $14.00 ($70K) on 2013-06-27, disclosed to the SEC on 2013-06-27.
Scheduled sale ($70k) by SVP of Medical & Clinical under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.00 | 1,867 | $26K | 37.3% |
| 2 | $14.00 | 117 | $2K | 2.3% |
| 3 | $14.00 | 3,016 | $42K | 60.3% |
| Total | $14.00 avg | 5,000 | $70K | 100% |
| Filing → |
| CCXI | SELL | 2017-06-30 | $760K | — | Filing → |
| CCXI | SELL | 2016-12-20 | $134K | — | Filing → |
| CCXI | SELL | 2016-12-07 | $255K | — | Filing → |